About Us
AST Holding is an innovative technology company specializing in the development and implementation of advanced solutions in the field of nutritional supplements and pharmaceuticals. Thanks to its unique know-how and many years of experience in the field of processing bioactive substances, AST Holding brings to the market new generation products with exceptional efficacy and safety.
The company is also a co-owner of the TEPCO GmbH manufacturing plant in Lustenau, Austria – an established manufacturer with more than 20 years of tradition in the field of top nutraceutical products and dietary supplements. The production process meets the highest quality standards, including the GMP (Good Manufacturing Practice) standard.
Our mission
AST Holding is committed to bringing scientifically based, effective and safe solutions to the market that are based on the latest scientific knowledge while respecting the natural origin of raw materials.
Goal
Our goal is to help people improve their quality of life, strengthen their immune system, and offer them innovative tools to protect their health in a changing world.
Subsidiaries and structure of the AST group
- TEPCO GmbH, Lustenau (AT): Research and Development (R&D) center and pilot production.
- ASTechnologies CZ sro (CZ): Main manufacturing plant for ImmunoSTATERA™ products.
- AST-Germany GmbH, Berlin (DE): Distribution center for the EU market.
The ImmunoSTATERA™ product line
ImmunoSTATERA™ represents the flagship of the AST group - a comprehensive line of innovative products developed to support immunity, regeneration and protection of the body.
The products are based on patented molecular solubilization technology, which:
- increases the bioavailability of active ingredients several times,
- allows the application of even poorly soluble natural compounds,
- guarantees the stability and purity of the final formulations.
Main advantages of ImmunoSTATERA™ products:
- Synergistic combination of natural phytochemicals (coumarins, flavonoids, polyphenols).
- Various galenic forms (oral drops, transdermal patches, functional teas).
- Scientifically based mechanisms of action (anti-inflammatory, antioxidant, epigenetic).
- European production and quality control
Vision and strategy
The AST Group aims to establish itself as a European leader in nanotechnology and solubilization solutions for nutraceuticals and transdermal systems.
Our key strategic pillars:
1. Innovation – continuous research and development of new technologies and formulations.
2. Quality – adherence to strict production standards and transparent documentation.
3. Partnerships – cooperation with universities, clinics and distribution networks across the EU.
4. Sustainability – ecological processes and natural resources in line with "green health" trends.